For Healthcare Organizations
Evaluate Post-Discharge Visibility in Your Own Workflow
MedSafe Follow-Up is designed for hospitals and healthcare organizations that want a structured way to identify post-discharge medication and recovery signals, prioritize follow-up, and measure program activity without requiring a major technology implementation for the initial evaluation.
The pilot addresses a specific gap: hospitals often have limited visibility into what happens after discharge — including potentially avoidable 30-day utilization that carries operational and financial consequences.
What the Initial Evaluation Includes
Focused Deployment
Begin with a defined hospital unit or service line and a 30-day enrollment period.
Lightweight Setup
No EHR integration is required for the initial configuration, and patients do not need to download an app or create an account.
Structured Follow-Up Visibility
The hospital can monitor patient engagement, identified barriers, clinical follow-up activity, resolution and Day-30 outcomes.
Organization-Specific Evaluation
Results are reviewed within the context of the organization’s own workflow, patient population and operational priorities.
A Low-Risk Way to Evaluate the Model
The initial MedSafe Follow-Up hospital pilot is offered at no cost. The purpose is to allow the organization to evaluate clinical workflow fit, operational burden, patient engagement, follow-up activity and measurable program results before making a purchasing decision.
Pilot results are organization-specific operational findings. No claims are made regarding guaranteed readmission reduction, clinical outcomes, or validated platform effectiveness.
Designed to Minimize Implementation Burden
No Initial EHR Integration
The initial configuration does not require EHR integration.
No Patient App or Account
Patients access the Recovery Passport through the hospital-provided QR/token workflow.
Privacy-Minimized Architecture
The current pilot configuration is designed to operate without PHI stored in MedSafe.
What Organizations Can Evaluate
- Enrollment and Initial Assessment completion
- Medication-understanding gaps
- Patient-reported barriers and recovery concerns
- Episodes identified for follow-up
- Clinical review and callback activity
- Barrier resolution
- Day-30 completion
- 7-, 14-, and 30-day readmission outcomes when entered by authorized hospital staff
- Patient-reported support experience when available
Readmission outcomes are entered by authorized hospital staff for internal quality-improvement evaluation. MedSafe Follow-Up does not assert a causal relationship between platform use and readmission outcomes.
Organization-Specific Value Analysis
Potentially avoidable 30-day utilization matters operationally and financially — through emergency care, readmissions, quality performance, and the clinical resources required to manage them. MedSafe Follow-Up is designed to help surface post-discharge needs earlier.
Under the CMS Hospital Readmissions Reduction Program (HRRP), eligible hospitals can receive a payment reduction ranging from 0% to 3%, applied to Medicare fee-for-service base operating DRG payments for eligible hospitals during the fiscal year.
MedSafe Follow-Up does not claim that every readmission is preventable or that use of the platform independently reduces readmissions or guarantees financial savings.
Source: CMS Hospital Readmissions Reduction Program
Evaluation agreements may include a customized organization-specific financial and operational impact model.